AngioDynamics (NASDAQ:ANGO) Updates FY 2025 Earnings Guidance

AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of -0.380–0.340 for the period, compared to the consensus earnings per share estimate of -0.400. The company issued revenue guidance of $282.0 million-$288.0 million, compared to the consensus revenue estimate of $283.9 million. AngioDynamics […]

Leave a Reply

Your email address will not be published.

Previous post Sparta Capital (CVE:SAY) Shares Down 25% – Should You Sell?
Next post The Toronto-Dominion Bank (TD) to Issue Quarterly Dividend of $1.05 on January 31st